id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
ajlm-1282	Admou, Brahim; Hachimi, Abdelhamid; Samkaoui, Mohammed Abdenasser	How can clinical immunology laboratories contribute to the management of severe COVID-19 cases in limited resource contexts?	2020		.htm	text/html	1833	97	39	More developed flow cytometry platforms allow for comprehensive phenotyping assays, enabling the investigation of naive, memory and regulatory T cells; in severe COVID-19 patients, early data on T cell subpopulation abnormalities show increased naive helper T cells and decreased memory helper T cells, associated with a lower number of regulatory T cells.10 Using a receiver operating characteristic curve to compare fatal and recovered COVID-19 cases, Xu et al.2 considered 559 cells/µL, 235 cells/µL, and 104 cells/µL of CD3+, CD4+T, and CD8+ T cell subsets as warning values, below which there was a significantly higher risk of in-hospital death.2 Indeed, there is a need for regional data analyses before determining cut-off values of these T cell subsets. How can clinical immunology laboratories contribute to the management of severe COVID-19 cases in limited resource contexts?	cache/ajlm-1282.htm	txt/ajlm-1282.txt